Evidence map›Paper›PMID 39144769›Full record

ArticleSchizophrenia bulletin open2022

Sleep in Psychotic Disorders: Results From Nationwide SUPER Finland Study.

Erik Cederlöf, Minna Holm, Markku Lähteenvuo, Willehard Haaki, Jarmo Hietala, Katja Häkkinen, Erkki Isometsä, Tuomas Jukuri, Risto Kajanne, Olli Kampman and 13 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Erik CederlöfPopulation Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID https://orcid.org/0000-0003-2911-1794
Minna HolmPopulation Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Markku LähteenvuoInstitute for Molecular Medicine Finland (FIMM), Helsinki, Finland.ORCID https://orcid.org/0000-0002-7244-145X
Willehard HaakiDepartment of Psychiatry, University of Turku, Turku, Finland.
Jarmo HietalaDepartment of Psychiatry, University of Turku, Turku, Finland.
Katja HäkkinenInstitute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
Erkki IsometsäDepartment of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Tuomas JukuriDepartment of Psychiatry, Oulu University Hospital, Oulu, Finland.
Risto KajanneInstitute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
Olli KampmanFaculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.
Tuula KieseppäDepartment of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Kaisla LahdensuoDepartment of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Jouko LönnqvistPopulation Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Teemu MännynsaloSocial Services and Health Care Sector; City of Helsinki, Helsinki, Finland.
Jussi Niemi-PynttäriSocial Services and Health Care Sector; City of Helsinki, Helsinki, Finland.
Kimmo SuokasFaculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.
Jaana SuvisaariPopulation Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Jari TiihonenNiuvanniemi Hospital, University of Eastern Finland, Finland.
Hannu TurunenPopulation Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.
Asko WegeliusDepartment of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Juha VeijolaDepartment of Psychiatry, Oulu University Hospital, Oulu, Finland.
Aarno PalotieInstitute for Molecular Medicine Finland (FIMM), Helsinki, Finland.
Tiina PaunioPopulation Health Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.ORCID https://orcid.org/0000-0002-5560-0666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Characterizing sleep in patients with schizophrenia, schizoaffective disorder, bipolar disorder, and psychotic depression. Methods: This cross-sectional questionnaire study is based on the SUPER study sample, which is part of the Stanley Global Neuropsychiatric Genomics Initiative. The study is a multicentre, nationwide Finnish study consisting of patients ( Results: Patients had more sleep problems compared with the general population, especially young and middle-aged patients (Difficulties initiating sleep in young patients odds ratio = 12.3, 95% CI 9.8-15.4). Long sleep duration was the most deviating property of the sleep characteristics, being particularly common among young patients with schizophrenia (odds ratio = 27.9, 95% CI 22.1-35.2, 47.4% vs 3.3% prevalence). All sleep problems were associated with worse subjective health. We also conducted a latent class analysis, resulting in a cluster relatively free of sleep problems (58% of patients), an insomnia symptom cluster (26%), and a hypersomnia symptom cluster (15%). Conclusions: In our sample, patients with psychotic disorders have more sleep problems-especially long sleep duration but also insomnia symptoms-compared with the general population. The patients can in a latent class analysis of their sleep symptoms be divided into groups with differing sleep profiles.

Indexed as

cluster analysishypersomniainsomniasleep problems

Identifiers

PMID39144769
PMCPMC11206061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.